Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(100.0%)
2Total
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04831086Phase 3Completed

To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis

Role: collaborator

NCT05073718Phase 3Completed

SARS-CoV-2 and Acetylsalicylic Acid (SARA)

Role: collaborator

NCT04465474Recruiting

Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)

Role: collaborator

NCT04379258Completed

Analysis of Mortality of Critically Ill Patients With COVID-19

Role: collaborator

All 4 trials loaded